LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Larry Chen: New Managing Director at Bioventus
Company News

Larry Chen: New Managing Director at Bioventus

March 17, 2021 1 min read Premium comments

Advertisement

Larry Chen: New Managing Director at Bioventus
#bioventusSecondary#larrychen

Armed with more than 20 years of experience in sales and marketing, Larry Chen, formerly director, Asia Pacific at Zipline Medical, Inc., has been named Managing Director, China and Asia Pacific for Bioventus Inc. Chen, whose prior roles were at health care companies with a presence in the region, will be based in Shenzhen, China.

“We are glad to welcome Larry to Bioventus and look forward to leveraging his experience and relationships in both China, as we explore our expansion opportunities there, and throughout the Asia Pacific region,” said John Nosenzo, Chief Commercial Officer, Bioventus. “We believe patients and clinicians will benefit greatly from our solutions in osteoarthritic joint pain, minimally invasive trauma and bone graft substitutes.”

Chen spent four years at Zipline Medical as director, Asia Pacific, until the company was acquired by Stryker Corporation. Previously, Chen was sales director, and later marketing director, Greater China, for Smith & Nephew; he also spent time at ArthoCare Corporation where he served in regional sales and marketing roles.

His work experience also includes Asia Pacific regional commercial leadership roles at Johnson & Johnson Medical/Ethicon, Mentor Corp. and Stryker. Chen’s initial work experience was as an export sales manager at China Qing ’An International Trading in Beijing.

Chen earned an MBA from the University of Leuven and a Bachelor of Science in Economics from the University of International Business and Economics in Beijing.

Chen told OTW, “It is exciting to be a part of Bioventus as the company puts more focus on Asia, especially China, and to have the opportunity to plan and actively relaunch our products in markets within Asia where we have a presence. In addition, I look forward to identifying new market for our products.”

As for how will proceed initially, Chen commented to OTW, “I will assess current coverage, representation and engagement of our distribution partners, visit markets to speak with customers and look to identify best practices across regions and segments, both in and outside of the company.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy